GlobeNewswire Inc | Jan 31, 2022 08:00AM EST

January 31, 2022

ROCHESTER, Mich., Jan. 31, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the Company)(Nasdaq: OPRX),a leading provider of point-of-care technology solutions helping patients start and stay on therapy announced today that members of its leadership team will attend and present at the upcoming 11th Annual SVB Leerink Global Healthcare Conference and BTIGs MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

Events Details

SVB Leerink, 11Th Annual Global Healthcare Conference

A fireside chat with Will Febbo, CEO, OptimizeRx: February 17Time: 10:00 AM ET

OptimizeRxs leadership team will be available for virtual one-on-one meetings. For more information please visit: SVB Leerink.

BTIG, MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Company presentation: February 15Time: 1:00 - 1:25 PM ET

OptimizeRxs leadership team will be available for virtual one-on-one meetings. For more information please visit: BTIG.

About OptimizeRxOptimizeRx is the best-in-class health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through atechnology platform embedded within aproprietary point-of-carenetwork, OptimizeRxhelpspatients start and stay on their medications.

For more information, follow the company onTwitter,LinkedInor visit www.optimizerx.com.

Important Cautions Regarding Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as anticipates, believes, estimates, expects, forecasts, intends, plans, projects, targets, designed, could, may, should, will or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Companys expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Companys growth, business plans and future performance. These forward-looking statements are based on the Companys current expectations and assumptions regarding the Companys business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Companys Annual Report on Form 10-K for the fiscal year endedDecember 31, 2020, its subsequent Quarterly Reports on Form 10-Q, and its other filings with theSecurities and Exchange Commission.

OptimizeRxContact

Andy DSilva, SVP Corporate Financeadsilva@optimizerx.com

Media Relations ContactMaira Alejandra, Media Relations Managermalejandra@optimizerx.com

Investor Relations ContactAshley RobinsonLifeSci Advisors, LLCarr@lifesciadvisors.com